Sunday, September 27, 2009
South Africa cruise to five-wicket victory
Thursday, September 24, 2009
Dilshan and Mendis drub South Africa in rain-hit game
Sunday, August 16, 2009
Steyn cleared of doping violation
Dale Steyn, the South Africa fast bowler, has been cleared by the IPL of any doping violation, Gerald Majola, Cricket South Africa's chief executive, has said. Steyn had come under the Doping Cloud when CSA acknowledged an "adverse finding" against him following a test conducted during the second IPL, but attributed the result to legitimate painkillers he had taken at the time.
However, Majola said on Wednesday that the IPL had cleared him of any violation. "There was a discrepancy in the result of a doping test during the IPL," Majola said. "But the authorities are perfectly satisfied with the explanation that Dale has provided and they have confirmed that no offence has been committed."
Steyn's use of painkillers during the IPL had resulted in the "marginal increase in the presence of morphene" in the sample. The IPL's testing agency had asked the player for a clarification on the finding, which prompted the South African board to submit a report explaining the situation.
Majola added that CSA remained totally committed to the ICC's anti-doping programme. Steyn will join the rest of the South Africa squad for a training camp in Potchefstroom towards the end of August ahead of the ICC Champions Trophy.
Steyn represented Royal Challengers Bangalore in just three matches in the second edition of the IPL and missed most of the action as a result of a thumb injury.
Friday, August 14, 2009
Graeme Smith Poses With The Champions Trophy
Tuesday, August 11, 2009
Steyn failed drug test during IPL
Cricket South Africa (CSA) has confirmed that Dale Steyn failed a dope test during the second IPL. It attributed the result to painkillers the fast bowler had taken during the tournament. Steyn was out of action for most of the IPL in South Africa in April-May due to a thumb injury and played only three matches for Bangalore Royal Challengers.
"We are aware of the result and submitted a report immediately to the IPL on why this has happened," Gerald Majola, CSA's chief executive told Cricinfo. "There was a marginal increase in the presence of morphine in the sample and that was due to painkillers he took during that period. We are awaiting a reply from the IPL authorities."
However, a Royal Challengers official said the franchise had no knowledge of this development. "Till Sunday night, Royal Challengers had no information/knowledge on this," Prakash Mirpuri, a vice-president of the UB Group, which owns the Bangalore franchise, told Cricinfo. "We can only comment if we receive official communication from CSA/IPL."
Dr Mohammad Moosajee, South Africa's team doctor and a member of CSA's medical committee, was confident Steyn wouldn't face any action despite the failed test, first reported by the sport24 website.
"This is not a doping violation as such but an adverse analytical finding, which is different," Moosajee told Cricinfo. "Dale is known to have a history of chronic migraines and he suffered a thumb injury too during the IPL and he was on Myprodol, a painkiller that contains codeine. Codeine converts to morphine within the body and that led to the adverse finding. Dale had taken the painkiller on the day of the test and the morphine level in his sample was found to be slightly higher (1.1 to 1.3 microgram per ml) than the 1 microgram per ml that is permitted.
"This is a matter between the IPL franchise and IPL but since Dale is also a CSA-contracted player, we were informed and we are now assisting in the process. We have sent a detailed report to the IPL and are awaiting a reply. We are confident that he will be cleared."
Codeine does not figure in the World Anti Doping Agency (WADA) list of prohibited substances but morphine has been classified under narcotics.
Moosajee said there was some confusion regarding the situation because the brand name of the painkiller is different in South Africa. "This also led to miscommunication in the Theraupatiuc Use Exemption (TUE) form that the player submitted before the test," Moosajee said. Players are expected to fill these TUE forms before a test so that the testers are aware of the medication the player is under.
Steyn is the second fast bowler to come under scrutiny for a failed drug test in the IPL; Pakistan's Mohammad Asif was banned for one year after testing positive for nandrolone, which is a banned substance, in the inaugural season in 2008.
In Asif's case, Lalit Modi, the IPL commissioner, had said that the first step was to match the identity of the player with the sample. Next, the player's form, filled out before the match, will be scrutinised for any pre-declared or prescribed drug by the IPL medical committee; if that matches the drug found in the sample, the matter ends there.
If the medical committee investigation reveals the player had not applied or been granted an exemption for using the drug found in the sample, the player, the concerned IPL franchise and national board will be informed in writing of the positive test that violates the anti-doping code. The player has the right to request that his 'B' sample [supplied at the same time as the one that tested positive] be sent for analysis, which he and his representative can attend along with an IPL representative.
If that too is positive, the matter will be taken up by the IPL's drugs tribunal, which will study the issue and take a decision in accordance with the code.
Monday, August 10, 2009
Gibbs picks Deccan over Cape Cobras
South African batsman Herschelle Gibbs has said that he will represent the Deccan Chargers in the Champions Twenty20 League. Gibbs, who was part of the victorious Deccan team that won the second edition of the IPL, chose the Indian franchise over his home side Cape Cobras, which would also be competing in the tournament featuring domestic Twenty20 champions from South Africa, Australia, England, New Zealand, Sri Lanka and West Indies.
"Yes, I will indeed come down to India once again soon and it will be my pleasure to represent the Chargers in the Champions Twenty20 League," Gibbs told the Deccan Chronicle.
Gibbs played a key role in Deccan's triumph in the IPL, held in South Africa this year. He was the second highest run-getter for them (behind captain Adam Gilchrist) with 371 runs at 33.72, which included four fifties and a strike-rate of 112.08 in the 14 matches.
The Cape Cobras will be compensated for the loss of Gibbs. "There is a provision in the tournament participation agreement wherein a team has to be compensated $200,000 if a player doesn't represent the home side in the Champions League," Andre Odendaal, the Cape Cobras CEO, said.
The Cape Cobras and Diamond Eagles would be South Africa's representatives in the Champions League, which runs from October 8-23, while Deccan would represent India along with Royal Challengers Bangalore and Delhi Daredevils in the tournament which carries $6 million prize money.
The Cape Cobras, who beat the Eagles in the final of the Pro20 series in South Africa this year, will play Bangalore, the IPL runners-up, in the opening game of the Champions League. Deccan will kick off their campaign two days later against a yet-to-be-decided English opposition.

